CTN :42539796
28 Jan, 2026
NA
Tender For corrigendum : supply of sch i (supply of injections & sera vaccines) - sch i (supply of injections & sera vaccines), inj. b complex for prophylactic use vit. c 150 mg vit. b 12 2500 mcg folic acid 0.7 mg niacinamide 12 mg, inj. b complex for therapeutic use each ml contain vit a 1000 iu cholecalciferol 100 iu alphatochopherol acetate 0.5 mg. thiamine 5 mg. pyridoxine 0.5 mg. nicotinamide 10 mg. ascorbic acid 50 mg. d-panthenol 2.5 mg., inj. calcium gluconate 10% iv use., inj. desferroxamine 500 mg, inj. digoxin 0.5 mg iv use, inj. diltiazem 5 mg/ml, inj. fluconazole 200 mg. in plastic bottle, inj. fluorescein sodium (20%), inj. hydralazine 20 mg. iv, inj. hyaluronidase 1500 iu, inj. insulin plain (purified human) 40 units/ml sc/iv use (insulin plain and insulin nph/ lente should be of the same manufacturer and their rate will be considered as a unit.), inj.insulin nph/isophane40 iu (highly purified bovine porcine isophane insulin susp 40 i.u./ml nph insulin (or neutral protamine hagedorn)., inj. isoxsuprine hcl 10 mg/ml., intravenous injection of n (2)-l alanyl-l glutamine 20%, solution 50 ml, iv lipid 20% for neo-natal use., inj.lorazepam 2 mg/ml im/iv use., inj. l-ornithine l-aspartate 5 gm, inj. n-butyl cyanoacrylate 0.5 gm., inj. methylene blue 10 mg/ml, inj. metoprolol 5mg, nitroglycerine lingual spray in ready to use formulation. each spray should deliver 0.35 to 0.4 mg/spray 60-70 lit/spray., inj. phenobarbitone sodium 200 mg iv use, inj. protamine sulphate 1% iv use, inj. somatostatin 3 mg /vial, sterile & pyrogen free water for injection i.p 5ml, inj.sterile & pyrogen free water for injections i. p. 10 ml, inj. thiamine 100 mg/ml, inj. tricort triamcinolone sodium 10 mg, inj. tuberculine p. p. d. 5 t. u./0.1 ml intradermal use., inj. vit. k 10 mg/ml (aqueous) i. m./i. v., inj. valethamate bromide 8 mg, inj. benzathine penicillin 6 lacs unit for im use, inj. benzathine penicillin 12 lacs unit im use, inj. benzyl penicillin/ penicillin g/ crystalline penicillin salt 1000000 units/bulbs i. m./i. v., inj. ofloxacin 200 mg, inj. streptomycin sulphate 0.75 gm, inj. anti d 300 microgram/dose polyclonal/monoclonal, inj. diptheria antitoxin 10000 iu, inj. hepatitis b vaccine recombinant dna technology 20 mcg/ml, inj. hib vaccine 10 mcg. haemophilus influenza type b. polysacchride conjugate vaccine. [powder to be reconstituted with 0.5 ml diluent (saline)]., inj. human rabies immunoglobulin 150 i.u./ml, inj meningococcal conjugate vaccine single dose vial containing (a, c, y & w 135) polysaccharide conjugated to diptheria toxoid class="text-red-selected">protein carrier.,
inj. mmr va
ccine (measles, mumps & rubella) single dose im or s
c.,
inj. pneumovax (pneumo
co
ccal 23 valent va
ccine),
inj. polyvalent antisnake venom serum- should
contain equivalent of 10 ml of purified globulins 1 ml of re
constituted serum to neutralizes 0.5 mg to 0.6 mg of dried
cobra venom, 0.45 mg of dried
common krait venom, 0.6 mg. of dried russells viper venom, 0.45 mg of dried saw s
caled viper venom, liquid or powder form will be a
ccepted,
inj. rabies human mono
clonal antibody (rdna) 40 iu/ml.,
inj. tetanus va
ccine purified toxoid adsorbed i. p. 5 lf./0.5ml,
inj. tetanus immunoglobulin (human) 250 i. u. im / intrathe
cal use.,
inj. tetanus immunoglobulin (human) 500 i. u. im / intrathe
cal use.,
inj. ligno
caine 10% spray,
inj. propofol 1% m
ct/l
ct fat emulsion with sodium oleate 50 ml,
inj. ropiva
caine h
cl 0.5%,
inj. 2% hydroxypropyl methyl
cellulose preservative free sterile for intrao
cular use during
catara
ct surgery in sterile prefilled syringe & with sterile
cannula., intra
cameral
inje
ction ligno
caine hydro
chloride 1%,
inj. perfluoro-n-o
ctane liquid for intrao
cular use sterile,
inj. pilo
carpine (0.5%) nitrate/h
cl sterile opthalmi
c solution for
inje
ction.,
inj. sili
con oil for (polydimethyl siloxane for intrao
cular use) sterile vis
cosity 1500 mm2/s
cst,
inj. sodium hyaluronate 1.4%,
inj. sodium hyaluronate 1.8%,
inj.
continuous ambulatory peritoneal d